{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:23:49Z","timestamp":1791829429041,"version":"4.3.4"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,7,18]],"date-time":"2027-07-18T00:00:00Z","timestamp":1815868800000},"content-version":"am","delay-in-days":320,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007737","name":"St. Jude Children's Research Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001368","name":"V Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000098","name":"National Institutes of Health Clinical Center","doi-asserted-by":"publisher","award":["U54 CA243124"],"award-info":[{"award-number":["U54 CA243124"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.modpat.2026.101032","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T07:01:10Z","timestamp":1782802870000},"page":"101032","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunophenotypic, Cytogenetic, and Molecular Characterization of NUP98-Rearranged Pediatric Myeloid Neoplasms"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6412-6943","authenticated-orcid":false,"given":"Mahsa","family":"Khanlari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beenu","family":"Thakral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Branko","family":"Cuglievan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghayas C.","family":"Issa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick R.","family":"Blackburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Key","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Westover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey E.","family":"Rubnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery M.","family":"Klco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 6","key":"10.1016\/j.modpat.2026.101032_bib1","article-title":"Children\u2019s Oncology Group\u2019s 2023 blueprint for research: myeloid neoplasms","volume":"70","author":"Cooper","year":"2023","journal-title":"Pediatr Blood Cancer"},{"issue":"6","key":"10.1016\/j.modpat.2026.101032_bib2","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S1535-6108(02)00211-8","article-title":"Acute leukemia: a pediatric perspective","volume":"2","author":"Downing","year":"2002","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.modpat.2026.101032_bib3","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.3390\/cancers13102336","article-title":"Survival following relapse in children with acute myeloid leukemia: a report from AML-BFM and COG","volume":"13","author":"Rasche","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"4","key":"10.1016\/j.modpat.2026.101032_bib4","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/bjh.14720","article-title":"Outcome after intensive reinduction therapy and allogeneic stem cell transplant in paediatric relapsed acute myeloid leukaemia","volume":"178","author":"Karlsson","year":"2017","journal-title":"Br J Haematol"},{"issue":"16","key":"10.1016\/j.modpat.2026.101032_bib5","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.3390\/cancers15164171","article-title":"Risk-stratified therapy for pediatric acute myeloid leukemia","volume":"15","author":"Tomizawa","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"8","key":"10.1016\/j.modpat.2026.101032_bib6","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1182\/blood-2012-02-408336","article-title":"Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group","volume":"120","author":"Loken","year":"2012","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.modpat.2026.101032_bib7","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.3324\/haematol.2022.281653","article-title":"Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia","volume":"108","author":"Bertrums","year":"2023","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.modpat.2026.101032_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41588-023-01640-3","article-title":"A new genomic framework to categorize pediatric acute myeloid leukemia","volume":"56","author":"Umeda","year":"2024","journal-title":"Nat Genet"},{"issue":"20","key":"10.1016\/j.modpat.2026.101032_bib9","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1182\/blood.2020007093","article-title":"Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies","volume":"136","author":"Michmerhuizen","year":"2020","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.modpat.2026.101032_bib10","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/sj.leu.2404130","article-title":"NUP98 rearrangements in hematopoietic malignancies: a study of the Groupe Francophone de Cytogenetique Hematologique","volume":"20","author":"Romana","year":"2006","journal-title":"Leukemia"},{"issue":"24","key":"10.1016\/j.modpat.2026.101032_bib11","doi-asserted-by":"crossref","first-page":"6247","DOI":"10.1182\/blood-2011-07-328880","article-title":"NUP98 gene fusions and hematopoietic malignancies: common themes and new biologic insights","volume":"118","author":"Gough","year":"2011","journal-title":"Blood"},{"issue":"17","key":"10.1016\/j.modpat.2026.101032_bib12","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1182\/blood.2025028993","article-title":"Fusion oncoproteins and cooperating mutations define disease phenotypes in NUP98-rearranged leukemia","volume":"146","author":"Umeda","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.modpat.2026.101032_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/1609128","article-title":"Mutated WT1, FLT3-ITD, and NUP98-NSD1 fusion in various combinations define a poor prognostic group in pediatric acute myeloid leukemia","volume":"2019","author":"Niktoreh","year":"2019","journal-title":"J Oncol"},{"issue":"9","key":"10.1016\/j.modpat.2026.101032_bib14","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1182\/bloodadvances.2023011980","article-title":"Prognostic impact of cooccurring mutations in FLT3-ITD pediatric acute myeloid leukemia","volume":"8","author":"Tarlock","year":"2024","journal-title":"Blood Adv"},{"issue":"26","key":"10.1016\/j.modpat.2026.101032_bib15","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1182\/blood-2016-01-695551","article-title":"Recurrent abnormalities can be used for risk group stratification in pediatric AMKL: a retrospective intergroup study","volume":"127","author":"de Rooij","year":"2016","journal-title":"Blood"},{"issue":"23","key":"10.1016\/j.modpat.2026.101032_bib16","doi-asserted-by":"crossref","first-page":"6000","DOI":"10.1182\/bloodadvances.2020002712","article-title":"Acute erythroid leukemia is enriched in NUP98 fusions: a report from the Children's Oncology Group","volume":"4","author":"Chisholm","year":"2020","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.modpat.2026.101032_bib17","doi-asserted-by":"crossref","first-page":"630","DOI":"10.3324\/haematol.2019.236745","article-title":"The clinical and biological characteristics of NUP98-KDM5A in pediatric acute myeloid leukemia","volume":"106","author":"Noort","year":"2021","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.modpat.2026.101032_bib18","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/ng.3772","article-title":"Pediatric non-Down syndrome acute megakaryoblastic leukemia is characterized by distinct genomic subsets with varying outcomes","volume":"49","author":"de Rooij","year":"2017","journal-title":"Nat Genet"},{"issue":"4","key":"10.1016\/j.modpat.2026.101032_bib19","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/s41588-019-0375-1","article-title":"Genomic subtyping and therapeutic targeting of acute erythroleukemia","volume":"51","author":"Iacobucci","year":"2019","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.modpat.2026.101032_bib20","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.modpat.2026.101032_bib21","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.modpat.2026.101032_bib22","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia"},{"issue":"12","key":"10.1016\/j.modpat.2026.101032_bib23","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1038\/s41375-025-02774-5","article-title":"Clinical experience of using integrated whole genome and transcriptome sequencing as a framework for pediatric and adolescent acute myeloid leukemia diagnosis and risk assessment","volume":"39","author":"Voss","year":"2025","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.modpat.2026.101032_bib24","first-page":"518","article-title":"Strategies for identifying NUP98 rearrangements in adult myeloid neoplasms","volume":"111","author":"Yuen","year":"2026","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.modpat.2026.101032_bib25","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/PAS.0000000000002350","article-title":"Pediatric myeloid neoplasms with UBTF tandem duplications: morphologic, immunophenotypic, and clinical characterization","volume":"49","author":"Khanlari","year":"2025","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.modpat.2026.101032_bib26","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3324\/haematol.2024.286537","article-title":"Complete remission of NUP98 fusion-positive acute myeloid leukemia with the covalent menin inhibitor BMF-219, icovamenib","volume":"110","author":"Carraway","year":"2025","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.modpat.2026.101032_bib27","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1182\/blood.2021012806","article-title":"The menin-MLL1 interaction is a molecular dependency in NUP98-rearranged AML","volume":"139","author":"Heikamp","year":"2022","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.modpat.2026.101032_bib28","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000935","article-title":"The MLL-menin interaction is a therapeutic vulnerability in NUP98-rearranged AML","volume":"7","author":"Rasouli","year":"2023","journal-title":"Hemasphere"},{"issue":"8","key":"10.1016\/j.modpat.2026.101032_bib29","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.3324\/haematol.2023.284683","article-title":"UBTF tandem duplications in pediatric myelodysplastic syndrome and acute myeloid leukemia: implications for clinical screening and diagnosis","volume":"109","author":"Barajas","year":"2024","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.modpat.2026.101032_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.b.20037","article-title":"Immunophenotypic differences between diagnosis and relapse in childhood AML: implications for MRD monitoring","volume":"63","author":"Langebrake","year":"2005","journal-title":"Cytometry B Clin Cytom"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522600075X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S089339522600075X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:14:50Z","timestamp":1790378090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S089339522600075X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S089339522600075X"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101032","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunophenotypic, Cytogenetic, and Molecular Characterization of NUP98-Rearranged Pediatric Myeloid Neoplasms","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2026.101032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 United States & Canadian Academy of Pathology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101032"}}